CIK 0000898437 · Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043145961
- Phone
- (781) 457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-15 | Blanchard Cheryl R Director | Option exercise · Restricted Stock Unit | −25,131 | 25,132 | ||
| 2026-03-15 | McLeod Ian SVP, CAO & Treasurer | Option exercise | +2,658 | 24,888 | ||
| 2026-03-15 | McLeod Ian SVP, CAO & Treasurer | Shares withheld for taxes | −781 | $14.20 | $11K | 24,107 |
| 2026-03-15 | McLeod Ian SVP, CAO & Treasurer | Option exercise · Restricted Stock Unit | −2,658 | 2,659 | ||
| 2026-03-14 | Colleran David EVP, General Counsel, Corp Sec | Option exercise | +9,388 | 62,488 | ||
| 2026-03-14 | Colleran David EVP, General Counsel, Corp Sec | Grant or award | +4,694 | 67,182 | ||
| 2026-03-14 | Colleran David EVP, General Counsel, Corp Sec | Shares withheld for taxes | −4,168 | $14.20 | $59K | 63,014 |
| 2026-03-14 | Colleran David EVP, General Counsel, Corp Sec | Option exercise · Restricted Stock Unit | −9,388 | 18,777 | ||
| 2026-03-14 | Griffin Stephen D. President and CEO | Option exercise | +12,824 | 23,495 | ||
| 2026-03-14 | Griffin Stephen D. President and CEO | Grant or award | +6,412 | 29,907 | ||
| 2026-03-14 | Griffin Stephen D. President and CEO | Shares withheld for taxes | −5,944 | $14.20 | $84K | 23,963 |
| 2026-03-14 | Griffin Stephen D. President and CEO | Option exercise · Restricted Stock Unit | −12,824 | 25,649 | ||
| 2026-03-14 | Blanchard Cheryl R Director | Option exercise | +24,519 | 235,969 | ||
| 2026-03-14 | Blanchard Cheryl R Director | Grant or award | +24,520 | 260,489 | ||
| 2026-03-14 | Blanchard Cheryl R Director | Shares withheld for taxes | −14,728 | $14.20 | $209K | 245,761 |
| 2026-03-14 | Blanchard Cheryl R Director | Option exercise · Restricted Stock Unit | −24,519 | 49,040 | ||
| 2026-03-14 | McLeod Ian SVP, CAO & Treasurer | Option exercise | +3,774 | 22,518 | ||
| 2026-03-14 | McLeod Ian SVP, CAO & Treasurer | Grant or award | +1,161 | 23,679 | ||
| 2026-03-14 | McLeod Ian SVP, CAO & Treasurer | Shares withheld for taxes | −1,449 | $14.20 | $21K | 22,230 |
| 2026-03-14 | McLeod Ian SVP, CAO & Treasurer | Option exercise · Restricted Stock Unit | −3,774 | 7,550 |
Page 2 of 20 · 400 trades